TrialEuropean urology2024

Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without Orteronel.

Primo N Lara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.